This page should not be speedy deleted because...

edit

This page should not be speedily deleted because it provides information about a Biotechnology company that has a unique technology to create therapeutic bispecific antibodies, by engineering a region of immunoglobulins. It's currently the only company in the world that takes this approach to byspecific antibodies.